The pharmaceutical sector is experiencing a important shift in glucose therapy with the arrival of GLP-1 skin applications. These revolutionary methods offer a likely convenient option to injections for individuals managing diabetes mellitus type 2. By bypassing the necessity for frequent injections, GLP-1 skin devices promise to boost individual s